Citation Impact
Citing Papers
Interleukin-1 in the pathogenesis and treatment of inflammatory diseases
2011 Standout
A Meta-Analysis of Cytokines in Major Depression
2009 Standout
Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation
2017 Standout
Investigation of the molecular profile of basal cell carcinoma using whole genome microarrays.
2006
Basal cell carcinomas: attack of the hedgehog
2008 Standout
Why not treat human cancer with interleukin-1 blockade?
2010
From stress to inflammation and major depressive disorder: A social signal transduction theory of depression.
2014 Standout
The multifaceted regulation and functions of PKM2 in tumor progression
2014
American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer
2007 Standout
β-Arrestin-dependent Constitutive Internalization of the Human Chemokine Decoy Receptor D6
2004 StandoutNobel
Plasma levels of cytokines and soluble cytokine receptors in psychiatric patients upon hospital admission: effects of confounding factors and diagnosis
1999
Dendritic cells in cancer immunology and immunotherapy
2019 Standout
Serum IL‐1β, sIL‐2R, IL‐6, IL‐8 and TNF‐α in schizophrenic patients, relation with symptomatology and responsiveness to risperidone treatment
2001
Prognostic Factors in Non-small Cell Lung Cancer
2002
Considerations with the use of biological therapy in the treatment of rheumatoid arthritis
2004
Carcinoembryonic antigen (CEA) as tumor marker in lung cancer
2011
Increased tumor necrosis factor-alpha concentrations with interleukin-4 concentrations in exacerbations of schizophrenia
2008
Hypophosphatemia in critically ill patients
2012
Cerebrospinal Cytokine Levels in Patients with Acute Depression
1999
Urine markers for detection and surveillance of bladder cancer
2013
Prediction of severe ovarian hyperstimulation syndrome by free serum vascular endothelial growth factor concentration on the day of human chorionic gonadotrophin administration
1999
Oxidative stress in the pelvic cavity and its role in the pathogenesis of endometriosis
2016 Standout
Inflammatory Cytokine Alterations in Schizophrenia: A Systematic Quantitative Review
2007
Associations of Depression With C-Reactive Protein, IL-1, and IL-6: A Meta-Analysis
2009 Standout
Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes
2002 Standout
Human ADAR1 Prevents Endogenous RNA from Triggering Translational Shutdown
2018 StandoutNobel
Angiogenesis in ovarian follicular and luteal development
2000
Role of vascular endothelial cell growth factor in Ovarian Hyperstimulation Syndrome.
1998
Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2016 Standout
The pro- and anti-inflammatory properties of the cytokine interleukin-6
2011 Standout
Serum tissue polypeptide specific antigen (TPS): a complementary tumor marker to CA 15-3 in the management of breast cancer
2001
Vascular Endothelial Growth Factor and Angiogenesis
2004 Standout
Serum vascular endothelial growth factor concentrations and ovarian stromal blood flow are increased in women with polycystic ovaries
1998
Serum Cytokeratin 19 Fragment (CYFRA21-1) as a Prognostic Factor in Intrahepatic Cholangiocarcinoma
2007
Antitumour actions of interferons: implications for cancer therapy
2016
Extracellular Matrix Degradation and Remodeling in Development and Disease
2011 Standout
The IL-6/sIL-6R complex as a novel target for therapeutic approaches
2007
Chronic graft-versus-host disease
2003 Standout
EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2013
2013 Standout
The chemokine system in diverse forms of macrophage activation and polarization
2004 Standout
Lysosomal storage disorders
2005
Cytokines sing the blues: inflammation and the pathogenesis of depression
2005 Standout
Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient
2016 Standout
Transforming Growth Factors β1 and β2 in the Cerebrospinal Fluid of Chronic Schizophrenic Patients
1997
Signalling pathways of the TNF superfamily: a double-edged sword
2003 Standout
Infliximab Maintenance Therapy for Fistulizing Crohn's Disease
2004 Standout
Interleukin-6-(IL-6) plasma levels in depression and schizophrenia: comparison between the acute state and after remission
1997
Bladder cancer
2016 Standout
Hypophosphatemia in the emergency department therapeutics
2000
Elevated Interleukin-6 in the Cerebrospinal Fluid of a Previously Delineated Schizophrenia Subtype
2003
Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK)
2005 Standout
Regulation, function and clinical significance of heparanase in cancer metastasis and angiogenesis
2006
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010
2011 Standout
Oncogene-Induced Senescence Relayed by an Interleukin-Dependent Inflammatory Network
2008 Standout
Higher Natural Killer Cell Activity in Schizophrenic Patients: The Impact of Serum Factors, Medication, and Smoking
2000
Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma
2014 Standout
Oxidative Stress in Cancer
2020 Standout
TNF-α targeted therapeutic approaches in patients with hematologic malignancies
2002
Urine Markers for Bladder Cancer Surveillance: A Systematic Review
2005
Markedly Elevated Levels of Vascular Endothelial Growth Factor in Malignant Ascites
1999
Worse Breast Cancer Prognosis of BRCA1/BRCA2 Mutation Carriers: What's the Evidence? A Systematic Review with Meta-Analysis
2015
Recurrence and Progression of Disease in Non–Muscle-Invasive Bladder Cancer: From Epidemiology to Treatment Strategy
2009 Standout
A sensitive amperometric immunosensor for carcinoembryonic antigen detection with porous nanogold film and nano-Au/chitosan composite as immobilization matrix
2007
Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia
2003 Standout
Vascular endothelial growth factor (VEGF) in endometriosis
1998
Meta-Analysis of Cytokine Alterations in Schizophrenia: Clinical Status and Antipsychotic Effects
2011 Standout
Monoclonal antibodies for the prevention and treatment of graft-versus-host disease
2003
Endometriosis
2004 Standout
CSF IL-1 and IL-2 in medicated schizophrenic patients and normal volunteers
1997
Recurrent miscarriage
2006 Standout
Interleukin‐6 and its receptor in cancer
2007
Molecular Markers for Bladder Cancer Screening, Early Diagnosis, and Surveillance: The WHO/ICUD Consensus
2014
Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2018 Standout
Decoy receptors: a strategy to regulate inflammatory cytokines and chemokines
2001
Muscle as an Endocrine Organ: Focus on Muscle-Derived Interleukin-6
2008 Standout
Alternative activation of macrophages
2003 Standout
Urinary Markers in Bladder Cancer
2007
Role of tumor necrosis factor-alpha inhibition with inflixiMAB in cancer therapy and hematopoietic stem cell transplantation
2000
Macrophage activation and polarization
2007 Standout
The kallikrein-kinin system, but not vascular endothelial growth factor, plays a role in the increased vascular permeability associated with ovarian hyperstimulation syndrome
1998
Demystifying the development of dendritic cell subtypes, a little
2008
Vascular Endothelial Growth Factor: Basic Science and Clinical Progress
2004 Standout
Human mesenchymal stem cells modulate allogeneic immune cell responses
2004 Standout
The Senescence-Associated Secretory Phenotype: The Dark Side of Tumor Suppression
2010 Standout
Pitfalls in the Measurement of Circulating Vascular Endothelial Growth Factor
2001
The extracellular matrix: A dynamic niche in cancer progression
2012 Standout
Elevated interleukin-6 in schizophrenia
1999
Aggregation-Induced Emission: Together We Shine, United We Soar!
2015 Standout
Vascular endothelial growth factor levels and induction of permeability in malignant pleural effusions.
1999
Serum Interleukin 1α and Interleukin 2 Levels in Patients with Schizophrenia
2002
Effect of neuroleptic administration on serum levels of soluble IL-2 receptor-alpha and IL-1 receptor antagonist in schizophrenic patients
2005
Hyperglycemic Crises in Adult Patients With Diabetes
2009 Standout
Gold Nanoparticles in Chemical and Biological Sensing
2012 Standout
Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care
2011 Standout
Inhibition of Toll-like Receptor and Cytokine Signaling—A Unifying Theme in Ischemic Tolerance
2004 StandoutNobel
Anti-TNF Therapy and Malignancy – A Critical Review
2001
Extracellular and intracellular decoys in the tuning of inflammatory cytokines and Toll-like receptors: the new entry TIR8/SIGIRR
2003
Antibody to Langerin/CD207 localizes large numbers of CD8α + dendritic cells to the marginal zone of mouse spleen
2009 StandoutNobel
Dual‐Amplification of Antigen–Antibody Interactions via Backfilling Gold Nanoparticles on (3‐Mercaptopropyl) Trimethoxysilane Sol‐Gel Functionalized Interface
2007
Cytokine serum levels, autologous mixed lymphocyte reaction and surface marker analysis in never medicated and chronically medicated schizophrenic patients
2001
Role of the Vascular Endothelial Growth Factor Pathway in Tumor Growth and Angiogenesis
2004 Standout
Works of Benjamin Nisman being referenced
Vascular endothelial growth factor plasma levels correlate to the clinical picture in severe ovarian hyperstimulation syndrome
1997
Prevalence of Hypophosphatemia in Sepsis and Infection: The Role of Cytokines
1998
Circulating Tumor M2 Pyruvate Kinase and Thymidine Kinase 1 Are Potential Predictors for Disease Recurrence in Renal Cell Carcinoma After Nephrectomy
2010
Cytokeratin Markers in Malignant Pleural Mesothelioma
1998
Cytokine Dysregulation in Chronic Graft Versus Host Disease
1995
The tumor necrosis factor family and correlation with disease activity and response to treatment in hairy cell leukemia
1999
Endocrinology: Plasma inflammatory cytokines correlate to the ovarian hyperstimulation syndrome
1996
CHANGES IN CYTOKINE PRODUCTION OF BREAST CANCER PATIENTS TREATED WITH INTERFERONS
1998
Evaluation of urine CYFRA 21‐1 for the detection of primary and recurrent bladder carcinoma
2002
Evaluation of tissue polypeptide specific antigen, CYFRA 21-1, and carcinoembryonic antigen in nonsmall cell lung carcinoma
1998
Changes in Interleukin-1β and Soluble Interleukin-2 Receptor Levels in CSF and Serum of Schizophrenic Patients
1995
An ELISA method for the detection and quantification of human heparanase
2006
The Prognostic Significance of Circulating Neuroendocrine Markers Chromogranin A, Pro-Gastrin-Releasing Peptide and Neuron-Specific Enolase in Patients with Advanced Non-Small-Cell Lung Cancer
2005
Cytokines in Gaucher's disease.
1999
Prognostic value of CYFRA 21-1, TPS and CEA in different histologic types of non-small cell lung cancer.
2000
Correlation of serum levels of interleukin-1 family members with disease activity and response to treatment in hairy cell leukemia.
1998
Serum thymidine kinase 1 activity in breast cancer
2010
1259 CYFRA 21-1 and TPS—new markers in lung cancer
1995